A Phase III Study of TMC435 in Genotype 1, Hepatitis C-infected Participants Who Failed to Respond to Previous IFN-based Therapy
Clinical trial NCT01288209 · COMPLETED
Trial details
- NCT number
- NCT01288209
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-09-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.